GlassScriptPhysician profile
Michele Schulz
NPI 1891778775
$1,546.60
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $26.68 · 2021: $274 · 2022: $177 · 2023: $16.92 · 2024: $813 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $477 · Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $477.30 |
| Food and Beverage | $453.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $636.30 | 2024 | |
| Heron Therapeutics, INC. | $164.10 | 2021-2022 | |
| Depuy Synthes Sales INC. | $161.97 | 2020-2022 | |
| Medtronic USA, INC. | $137.56 | 2019 | |
| Cornerstone Medical Associates, INC. | $108.82 | 2023-2024 | |
| Ethicon US, LLC | $102.03 | 2024-2025 | Surgicel Nu-Knit, Dermabond, Vistaseal |
| Davol INC. | $47.62 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $36.52 | 2025 | Pico, Pico 14 |
| Musculoskeletal Transplant Foundation INC. | $34.02 | 2022 | |
| Medical Device Business Services, INC. | $32.34 | 2021 | |
| Pacira Therapeutics, INC. | $29.98 | 2021 | |
| Horizon Therapeutics Plc | $20.49 | 2021 | |
| Heraeus Medical, LLC. | $19.10 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.75 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Schulz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.